It has been observed that interleukin (IL)-1, IL-6, cytoskeleton-associated protein 4 (CKAP4), and galectin-9 are all increased in both Alzheimer’s disease and COVID-19 [35]. Here, CKAP4 is linked to early-onset autosomal dominant Alzheimer disease.